Prescient Neuropharma, Inc.
Records under this name other than patents Prescient Neuropharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Prescient Neuropharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,425 | Dopaminergic neuronal survival-promoting factors and uses thereof Formerly held Lapsed on the fee record Ended Dec 27, 2019 · USPTO record | Lapsed on the fee record | Ended Dec 27, 2019 | USPTO record |
| US 9,115,208 | Dopaminergic neuronal survival-promoting factors and uses thereof Formerly held Lapsed on the fee record Ended Aug 25, 2019 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2019 | USPTO record |
| US 7,034,055 | 2-aminoindane analogs Lapsed on the fee record Ended Apr 25, 2010 · USPTO record | Lapsed on the fee record | Ended Apr 25, 2010 | USPTO record |
| US 6,784,202 | Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation Formerly held Lapsed on the fee record Ended Aug 31, 2008 · USPTO record | Lapsed on the fee record | Ended Aug 31, 2008 | USPTO record |
| US 6,699,909 | Novel Aminoindanes Formerly held Lapsed on the fee record Ended Mar 2, 2008 · High confidence | Lapsed on the fee record | Ended Mar 2, 2008 | High confidence |
| US 6,465,248 | Methods for producing and preparing cells for cell therapy Lapsed on the fee record Ended Oct 15, 2006 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2006 | USPTO record |